Antimicrobial Resistance News and Research

RSS

G7 health ministers sign landmark pact to make the world better prepared for future pandemics

A landmark pact signed by G7 health ministers in Berlin will help ensure the world is better prepared for future pandemics.

20 May 2022

New funding boost to combat antibiotic resistance

Antibiotics have saved countless lives since they were introduced in the 1940s, curing infections and making procedures like chemotherapy and surgeries safer. But their effectiveness is waning.

19 May 2022

Developing innovative approaches to combat urinary tract infections

The German government is providing about 2.4 million Euros for a new research group in infectious diseases at JMU Würzburg.

18 May 2022

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

The International Vaccine Institute, in collaboration with LG Electronics, the Ethiopian government led by Armauer Hansen Research Institute, and the Ethiopian Public Health Institute, will vaccinate 40,000 people against cholera in May to support prevention of the disease in Ethiopia.

13 May 2022

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

The International Vaccine Institute (IVI) and SK bioscience announced today that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for SK's typhoid vaccine 'SKYTyphoid' which they jointly developed.

12 May 2022

How is the Antimicrobial Resistance Crisis Impacting Sepsis?

In this interview, News-Medical talks to Dr. Ron Daniels about his work at the UK Sepsis Trust and the impact antimicrobial resistance is having on sepsis.

11 May 2022

Diet with higher amounts of soluble fiber may be a solution to reduce antimicrobial resistance

Healthy adults who eat a diverse diet with at least 8-10 grams of soluble fiber a day have fewer antibiotic-resistant microbes in their guts, according to a study published by Agricultural Research Service scientists and their colleagues in mBio.

10 May 2022

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.

5 May 2022

Researchers use a systems biology approach to parse the genetic diversity of C. difficile

Researchers at University of California San Diego School of Medicine and Jacobs School of Engineering, with colleagues at Baylor College of Medicine, have used a systems biology approach to parse the genetic diversity of Clostridioides difficile, a particularly problematic pathogen in health care settings.

27 Apr 2022

Study finds antimicrobial resistance rates to be significantly higher during the pandemic than before

Among those hospitalized during the pandemic, both COVID-19 patients and those tested for SARS-COV-2 but negative, had higher rates of antibiotic-resistant bacterial infections compared to patients hospitalized before the pandemic, according to a study evaluating the pandemic's impact on antimicrobial resistance (AMR) in 271 hospitals across the USA, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April).

25 Apr 2022

C. difficile study finds the sharing of multiple antibiotic-resistance genes between pigs and humans

A study investigating samples of the superbug Clostridioides difficile across 14 pig farms in Denmark finds the sharing of multiple antibiotic-resistance genes between pigs and human patients, providing evidence that that animal to human (zoonotic) transmission is possible.

24 Apr 2022

International Health Partners; Bringing Hope to Vulnerable Communities

In this interview, we speak to Adele Paterson, CEO of International Health Partners, about how they are bringing hope to vulnerable communities worldwide.

7 Apr 2022

New study finds community acquired drug-resistant UTIs to be more deadly

A new study led by Australia’s national science agency, CSIRO, has found the spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs), which affect around one in two women and one in 20 men in their lifetime.

6 Apr 2022

Antimicrobial Resistance News and Research

G7 health ministers sign landmark pact to make the world better prepared for future pandemics

New funding boost to combat antibiotic resistance

Developing innovative approaches to combat urinary tract infections

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

How is the Antimicrobial Resistance Crisis Impacting Sepsis?

Diet with higher amounts of soluble fiber may be a solution to reduce antimicrobial resistance

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

Researchers use a systems biology approach to parse the genetic diversity of C. difficile

Study finds antimicrobial resistance rates to be significantly higher during the pandemic than before

C. difficile study finds the sharing of multiple antibiotic-resistance genes between pigs and humans

International Health Partners; Bringing Hope to Vulnerable Communities

New study finds community acquired drug-resistant UTIs to be more deadly

Key mechanism that increases drug tolerance among microbial communities revealed

Antimicrobial resistance in COVID-19

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

Increasing trend of antimicrobial resistance in Eastern Mediterranean Region of World Health Organization

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

Bacterial coinfection pervasiveness and antibiotic use in COVID-19 patients

Using AI to detect antibiotic resistance

Microbiology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News